Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Document Type
Editorial
Publication Date
1-25-2018
Digital Object Identifier (DOI)
https://doi.org/10.1056/NEJMe1714638
Related Content
Disclosure forms provided by the author are available with the full text of this editorial at NEJM.org.
Repository Citation
Murphy, Michael Paul, "Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease" (2018). Molecular and Cellular Biochemistry Faculty Publications. 136.
https://uknowledge.uky.edu/biochem_facpub/136
Disclosure Forms
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Diseases Commons, Neurology Commons
Notes/Citation Information
Published in The New England Journal of Medicine, v. 378, no. 4, p. 391-392.
From The New England Journal of Medicine, M. Paul Murphy, Amyloid-Beta Solubility in the Treatment of Alzheimer’s Disease, 387, 391-392. Copyright © 2018 Massachusetts Medical Society. Reprinted with permission.